We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
06 Jun 2020 - 09 Jun 2020
Virtual Venue
08 Jun 2020 - 11 Jun 2020
Virtual Venue

Faster Way of Detecting Bacteria Developed

By LabMedica International staff writers
Posted on 16 Feb 2017
Print article
Image: The instrument used for the In-DX panel for rapidly detecting bacteria (Photo courtesy of G.L. Kohuth, Michigan State University).
Image: The instrument used for the In-DX panel for rapidly detecting bacteria (Photo courtesy of G.L. Kohuth, Michigan State University).
A faster way to detect the pathogenic bacteria that may cause patients to become sick has now been developed, giving physicians a better chance at saving lives by proscribing the most suitable antibiotic.

Today, patients generally have to wait days to get final test result, but the new method of testing of urine samples, for example, produces positive results in two hours from start to finish versus the days it can take for equivalent hospital laboratory tests.

Scientists at Michigan State University developed a point-of-care diagnostic test known as In-Dx. The detection process is relatively simple for both the patient and physician. A sample is collected and concentrated into a smaller amount. After applying heat, which breaks down the sample cells, it is then placed into the In-Dx testing panel and after 20 minutes of incubation time, the positive sample changes color, revealing the invading organism. The team is more than one year into a clinical trial that aims to validate the point-of-care diagnostic test, and the preliminary results already look promising.

The molecular diagnostic system can identify dangerous bacteria such as Escherichia coli, Staphylococcus infections, and even some superbugs. The test can produce results within two hours using blood, urine, saliva, wound, stool or cerebral spine fluid samples from infected patients. The team have concentrated on sepsis, a serious, life-threatening infection occurring more commonly in hospitalized patients, is one of the medical problems. If not treated properly, septic patients may have only hours to live. Currently, millions of people die each year worldwide partly because a definitive diagnosis of the sepsis-causing bacteria often takes too long.

Brett Etchebarne, MD, PhD, an assistant professor of emergency medicine, who helped develop the test said, “In-Dx has high sensitivity and specificity for detection of the most common infectious organisms which will help physicians quickly rule in or rule out specific bacteria. Knowing what your target is early in the fight against sepsis will be an invaluable advantage in helping maximize patient care strategies and outcomes.”


Print article

Channels

Copyright © 2000-2020 Globetech Media. All rights reserved.